A randomized phase II study comparing mFOLFOX-6 combined with axitinib or bevacizumab or both in patients with metastatic colorectal cancer (mCRC)
Infante, J. R., Cohn, A. L., Reid, T. R., Edenfield, W. J., Cescon, T., Hamm, J. T., Tarazi, J. C., Kim, S., Rosbrook, B., Cartwright, T. H.
Published in Journal of clinical oncology (01.02.2011)
Published in Journal of clinical oncology (01.02.2011)
Get full text
Journal Article
A phase II clinical trial of ZD1839 (gefitinib) in combination with docetaxel as first-line treatment in patients with advanced breast cancer
Dennison, S. K., Jacobs, S. A., Wilson, J., Seeger, J., Cescon, T., Raymond, J. M., Geyer, C. E., Wolmark, N., Swain, S. M.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article